One-Stop specialist visit could cut steroid use for asthma and nasal polyp patients
NCT ID NCT07134686
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study compares a joint consultation with both a lung doctor (pulmonologist) and an ear-nose-throat (ENT) specialist against separate visits for people with asthma and chronic sinusitis with nasal polyps. The main goal is to see if the joint approach reduces the need for oral steroids over one year. Researchers will also track asthma attacks, sinus events, symptoms, and quality of life in 195 adults.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- joint consultation with pulmonologist and ENT specialist
- What this could lead to
- If successful, this could show that a single joint visit with both specialists leads to better treatment plans, less need for steroids, and fewer flare-ups for people with asthma and nasal polyps.
- What could go wrong
- This is a small, early-stage study (195 participants) comparing care models, not testing a new drug. The results may not apply to all patients, and the benefit over standard care might be small or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI and a smartphone app may let kids with asthma skip clinic visits
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Short steroid course after first wheeze may stop asthma before it starts
- New antibody drug aims to tame Hard-to-Control asthma
- New asthma drug aims to improve breathing without daily pills
- Scientists compare two formulations of a potential asthma treatment